In stark contrast, homozygous mutations of CaSR cause neonatal severe hyperparathyroidism (NSHPT) which is associated with severe metabolic disturbances, growth retardation, and death [5, 6]. The gene discussed is CASR; the disease is neonatal severe primary hyperparathyroidism.